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Albumin interaction with the glomerular capillary wall in vitro. The
binding of albumin to the glomerular capillary wall was studied using
albumin-gold in perfused kidneys, the interaction of [3Hjalbumin with
isolated glomeruli at 37°C and 4°C and the interaction at [3H]albumin with
purified basement membrane. The albumin-gold was found to bind
predominantly to the basement membrane and this interaction could be
dissociated with high concentrations of albumin. There was binding of
albumin to isolated rat glomeruli which exhibited temperature depen-
dence. Glomeruli exhibited a binding site at both 37°C and 4°C with an
association constant in the range of ito 3 X io M1 that bound 7 X i0'
molecules/glomerulus, At 37°C, however, there was anomalous Scatchard
binding behaviour at relatively higher concentrations of albumin (30 to 50
mg/mI) which could be due to either glomerular cell uptake or the
appearance of multiple binding sites or both. The binding of albumin to
isolated glomeruli and the glomerular albumin levels in isolated kidney
perfusion could largely be accounted for by the binding of albumin to the
glomerular basement membrane. The albumin binding to glomeruli at
37°C was enhanced by Pronase digestion and heparinase digestion, but
remained unchanged following trypsin treatment or neuraminidase treat-
ment. Similarly, albumin was shown to bind to purified basement mem-
brane preparations. This binding was also enhanced (—80 times) by
heparinase digestion but remained unchanged after digestion with chon-
droitinase ABC or hyaluronidase. The studies suggest that there is binding
of albumin to the extracellular matrix components of the glomerular
capillary wall and that a significant number of binding sites can be revealed
on exposure to Pronase or heparinase. This work confirms the suggestion
of Kanwar and Rosenzweig (J Cell Biol 93:489—494, 1982) that heparan
sulfate may act as an anticlogging agent to the glomerular capillary wall.
The major barrier to albumin permeability in kidney ultrafil-
tration is the glomerular capillary wall (GCW). The capillary wall
consists of a vascular inner monolayer of endothelial cells that are
fenestrated (that is, have pores which in rats have diameters of 50
to 100 nm) which allows direct contact between the contents of
the blood plasma and the extracellular matrix of the GCW,
namely the glomerular basement membrane (GBM). Fenestra-
tion of glomerular capillaries represents approximately 10% of
the total capillary surface area [1] and is much greater than in any
other capillary bed in the body. Visceral epithelial cells (podo-
cytes) cover the outer part of the capillary wall and are exposed to
the Bowman's capsule. In normal filtration, the filtrates obtained
in the Bowman's capsule are essentially devoid of albumin and
other proteins and there is no evidence of fouling or clogging.
The transport of albumin across the GCW has been understood
primarily through studies that have employed test macromolecu-
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lar transport probes of varying size and charge. The marked
restriction to albumin transport has been considered to be a result
of a combination of a size exclusion effect and an electrostatic
charge repulsion effect by the anion charges of the GCW on the
anion charge of albumin [2]. The role of the anionic charges of the
GCW matrix glycosaminoglycans has been particularly high-
lighted in studies where in perfused kidneys an increased albumin
permeability resulted from treatment by glycosaminoglycan de-
grading enzymes [3]. Furthermore, clogging of the GCW occurred
when the influence of GCW anion charge was decreased by
increasing the ionic strength of the perfusate [4]. Cellular process-
ing, particularly at the level of the endothelial cell, has not been
considered to be significant as transport would most likely occur
through the lower resistant, highly fenestrated, extracellular route
[5].
The binding interaction of albumin with components of the
GCW has not been previously identified, although it has been
established that a significant amount of albumin is associated with
the glomerulus [6]. Albumin is recognized as a major determinant
of the integrity of the vascular barrier in governing fluid flow in
various capillaries beds, including the glomerulus [7—11]. This
effect is mediated by albumin binding to glycoproteins of endo-
thelial cell surfaces [12—15] and/or to the extracellular matrix
(often termed glycocalyx) components of the vascular wall [16—
18]. These findings have stimulated the present study with the aim
of examining whether there is a binding interaction of albumin to
matrix and cellular components of the GCW and whether this may
affect the anticlogging properties of the system. All the quantita-
tive binding studies have utilized tritium labeled albumin ([3H]al-
bumin), which has high specific activity and identical physico-
chemical properties to the unlabelled material [19] making it a
relevant physiological marker and a sensitive assay for binding.
Methods
Materials
Male Sprague-Dawley rats (300 to 350 g) were obtained from
the Monash University Central Animal House. Laboratory test
sieves (aperture size of 106, 125 and 180 m) used for isolation of
glomeruli were purchased from Endecotts Ltd. (London, UK).
Bovine serum albumin (Fraction V), Pronase (—7000 U/g from
Streptomyces griseus) and DNase I was purchased from Boehringer
Mannheim GmbH Biochemica (Mannheim, Germany). Dextran
T40 (molecular weight —40,000) and Sephadex G-25M in PD-b
columns were purchased from Pharmacia Fine Chemicals (Upp-
sala, Sweden). Nembutal (60 mg!ml) was from Cera Chemicals
(Australia Pty. Ltd., Hornsby, N.S.W., Australia). Synthamin 13 (a
source of amino acids) was from Travenol Laboratories (N.S.W.,
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Australia). The other amino acids used namely, lysine, tyrosine,
serine, cysteine, aspartate, glutamate, asparagine and glutamine
together with chondroitinase ABC (EC 4.2.2.4; 1.4 U/mg; Lot
43H4054), hyaluronidase (EC 3.2.1.35; 290 U/mg; Lot 96F-8240),
neuraminidase (from Clostridium perfringens; EC 3.2.1.18; 240
U/mg; Lot 127F805012), deoxycholate, EDTA, sodium acetate,
trypsin inhibitor (type 11-0 from chicken egg white), and the
enzyme inhibitors N-ethyl-maleimide (NEM), phenylmethylsul-
phonyl fluoride (PMSF), 6-aminohexanoic acid and benzamidine-
HCI were from Sigma Chemical Co. (St. Louis, MO, USA).
[-leparinase (from Flavobacterium heparinum) (30 U/mg) (EC
4.2.2.7) was purchased from IBEX Technologies (Montreal, Que-
bec, Canada; Lot 100.13.HA). Trypsin was purchased from
DIFCO Laboratories (Detroit, MI, USA). Papain was a gift from
Dr. H.C. Robinson, Biochemistry Department, Monash Univer-
sity. Tritiated water (5.55 >< 108 dpm/g) was from New England
Nuclear (Boston, MA, USA). Sodium boro-[3H]hydride (132
mCi/mg) was from Amersham International (Buckinghamshire,
UK).
Solutions and buffers
Phosphate buffered saline pH 7.4 contained 136.9 mM NaCI,
2.68 m'vi KCI, 8.1 ms Na2HPO4 and 1.5 mtvi KH2PO4. Krebs-
Henseleit buffer pH 7.4 contained 122 mM NaCI, 4.6 mivi KC1,
0.115 mM KH2PO4, 0.115 mi MgSO4, 24.9 mivi NaHCO3 and 0.1
mM CaCl 2H20. Normal kidney perfusate solution was 5%
bovine serum albumin in Krebs-Henseleit buffer that contained 5
m glucose, and amino acids (mM) tyrosine (0.2), serine (1.0),
cysteine (0.5), aspartate (0.2), glutamate (0.5), asparagine (0.2),
glutamine (2.0), leucine (0.4). phenylalanine (0.32), methionine
(0.33), lysine (1.0), isoleucine (0.3), valine (0.33), histidine (0.24),
threonine (0.24), tryptophan (0.07), alanine (2.0), glycine (2.3),
arginine (0.5) and proline (0.31). The enzyme inhibitor mixture
contained 10 ms NEM, 50 mM benzamidine HCI, 1 m 6-amino-
hexanoic acid and 0.1 M EDTA and is referred to as inhibitor
cocktail A.
All albumin solutions were made up by weight which took into
account the moisture of the material as determined by dry weight
analysis at 60CC under vacuum in the presence of a dessicant.
Tritium labeling of macromolecules
Bovine serum albumin was tritiated by the technique of Tack et
a! [20]. This reaction involves a reductive methylation associated
with a brief exposure to formaldehyde and sodium boro-[3H]hy-
dride. Tritiation of dextran T40 was carried out as described by
Van Damme, Comper and Preston [19] using a reductive tech-
nique with sodium boro-[3H]hydride. The labeled preparations
were then separated from free label on Sephadex G-25 PDIO
columns and dialyzed extensively. The final specific activity of the
[3H]albumin preparation was 4.1 )< 108 dpm/g and the [3H]dex-
tran preparation was 4.7 X 10 dpm/mg.
Kidney perfusion with albumin-gold
The perfusion technique has been described in detail [21].
Briefly, the kidneys were perfused with 5% bovine albumin in
modified Krebs-Henseleit buffer and was continually gassed with
95% 02-5% CO2. Albumin-gold (5 nm) was prepared according
to the method of Slot and Geuze [22]. Cluster analysis of aliquots
of albumin-gold samples placed on Butvan 98 coated grids and
examined at 100,000x demonstrated that for 120 particles 64%
were singlets, 18% doublets, 4% triplets and 14% >triplets. Prior
to use the albumin-gold solution was centrifuged at 12,000 g for
five minutes and the supernatant was recovered which had an
albumin-gold at concentration corresponding to AlOcm515, =
0.645; 65 ml of this solution was then made up to a total of 230 ml
to correspond to normal perfusate. The kidney was perfused for
approximately 20 minutes. The kidney was then flushed with
phosphate buffered saline at 3 mI/mm for approximately three
minutes and then a fixative consisting of 2.5% formaldehyde,
1.5% glutaraldehyde and 2.5 mrvi CaCI2 in 0.1 M HCI-Na cacody-
late buffer, pH 7.4 [12]. Only cortical tissue cut in —2 mm3 blocks
were immersed in the fixative. In another experiment albumin-
gold was used in phosphate buffered saline pH 7.4 and perfused
through the kidney for approximately two minutes. The kidney
was then fixed as described vide supra.
Isolation of glomeruli
Male Sprague-Dawley rats were anaesthetized by an intraperi-
toneal injection of 1 ml of Nembutal (18 mg/ml). Both kidneys
were removed through ventral incision and glomeruli were iso-
lated by a sieving method previously described by Spiro [231.
Briefly, the kidney was initially diced into small pieces. These were
then forced through a 125 j.m mesh sieve with the base of a glass
beaker and washed through with ice-cold 0.85% NaCI. The filtrate
was collected in a petri dish kept on ice. This filtrate was then
passed through a further two sieves, a 180 m mesh sieve placed
on top of a 106 .tm mesh sieve. Glomeruli were retained on top of
the 106 jzm sieve while the rest of the renal vasculature debris
passed through to a collecting pan. The glomeruli were washed
with ice-cold 0.85% NaCI to obtain a preparation free of cell
debris and fragments. The sieve was then inverted and the
glomeruli resting on it were washed off into a suspension with 7 ml
of 0.85% NaCl. The glomeruli preparation was then washed three
times with 0.85% NaCI, involving centrifugation in a KS-5200C
Kubota benchtop centrifuge at 700 rpm for three minutes and
then resuspension in fresh solvent. Glomeruli (approximately
40000 from 2 kidneys) isolated by this technique were essentially
free of the outer Bowman's capsule, were —95% pure, and
appeared normal as judged by transmission electron microscopy
(Vyas, unpublished observations). After adequate mixing five 20jd aliquots of the suspension were taken up into a calibrated
mierocapillary tube for counting under a phase contrast micro-
scope.
Glomendar basement membrane preparation
The method employed was a modification and combination of
techniques previously described by other investigators [24—281.
The suspension of glomeruli prepared from ten kidneys as
described above was pelleted in the bench centrifuge for two
minutes at 3000 rpm. The glomeruli were then suspended in 5.4
ml phosphate buffered saline pH 7.4 and 0.6 ml of inhibitor
cocktail A plus 30 jtl PMSF (0.2 M in propanol). The suspension
was then sonicated with a Sonicator Ultrasonic Processor (Heat
Systems, Farmingdale, NY, USA) using a microtip probe for 15
seconds, using a 0.3 second on and 0.7 second off cycle. The
output setting was controlled at 4.5. The resultant suspension was
centrifuged at 3700 rpm for 20 minutes at 4°C using a MSE
Centaur 2 centrifuge. The pellet was resuspended in 40 ml of 1 M
NaC1 containing 4000 units of DNase I, 4 ml of the inhibitor
cocktail A (hut without EDTA) and 30 jd of PMSF (0.2 M). The
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suspension was gently tumbled for two hours, after which it was
centrifuged for 20 minutes at 4°C on the MSE Centaur 2. The
pellet was resuspended in 40 ml of 1% deoxycholate, 0.1% sodium
azide and inhibitor cocktail A without EDTA, gently tumbled for
three hours and then centrifuged at 3500 rpm for 20 minutes at
4°C. Basement membrane preparation distributed equally to six
preweiglied Eppendorf tubes. These preparations were centri-
fuged for 45 seconds on the Beckman Microfuge B and washed
repeatedly (x6) with phosphate buffered saline. A wet weight of
the GBM pellet was obtained by centrifuging the preparation in
the Beckman Microfuge B for 2.5 minutes and blotting the pellet
with tissue paper until there was no apparent change in weight. Six
samples weighing 3 to 8 mg wet weight of GBM were obtained
using this procedure. The GBM was used at this stage for binding
experiments or total protein analysis.
Determination of protein content
GBM pellets of known wet weight were solubilized in 1.0 ml 0.2
M NaOH at 100°C for 15 minutes, The total protein was estimated
by the Lowry assay [29].
Enzyme digestions
Heparinase (mol wt 43,000) acts as an eliminase at the repeating
unit of heparin-like polysaccharides (—'4)2-deoxy-2-sulfamino-a-D-
glycopyranose-6-O-sulfate(or no sulfate)-(1---4)-c-L-idopyranosyl
uronic acid 2-O-sulfate(1—'). The heparinase preparation had no
chondroitinase ABC activity (according to the manufacturer) nor
proteolytic activity as tested by incubating 106 dpm of [3H]albumin
with 3 x iO U of heparinase for three hours at 37°C and the
examining the integrity of the [3H]albumin by gel chromatography.
The enzyme was stored in 900 d aliquots of 1.0 X 10—2 U/mI of 0.01
M Na2HPO4 and 0.15 M NaC1 at —20°C. For the enzyme digestion
one aliquot was used per 16,000 glomeruli. The isolated giomeruli
were suspended in 3 ml of 0.25 M sodium acetate, 2,5 m calcium
acetate buffer pH 7.0 and were incubated for two hours with gentle
tumbling at 37°C. At the end of the incubation the glomeruli were
washed in 0.85% NaCI prior to the binding assay. Heparinase
digestion of the GBM was carried out with 3 X i03 U of heparinase
for each 3 to 8 mg of GBM, after which the wet weight and total
protein were determined as described above.
Chondroitinase ABC digests chondroitin sulfate and dermatan
sulfate glycosaminoglycan chains. It was stored in 100 1.d aliquots
of 5 U/mi in 0.1 M Tris-HC1 buffer at —20°C. One aliquot was used
per GBM preparation (3 to 8 mg wet wt). GBM preparations were
suspended in 1 ml of 0.1 M Tris-HC1 with 0.01% BSA, 0.125%
NEM and 0.372% EDTA, pH 8.0 and incubated for two hours
with gentle tumbling at 37°C.
Hyaluronidase was stored in 333 .tl aliquots of 1 mg/ml in 0.2 M
acetate, 0.15 M NaCl, p1-1 5.5 buffer at —20°C. One aliquot was
incubated per GBM preparation (3 to 8 mg wet wt) in the same
buffer for two hours with gentle tumbling at 37°C.
Neuraminidase removes terminal sialic residues from oligosac-
charide chains. The enzyme (0.25 U) was incubated with —2,000
glomeruli in 1.0 ml of 0.1 M sodium acetate, 0.1 M NaC1, pH 5.4.
After incubation, the samples were centrifuged at 3,300 rpm for
three minutes, the supernatant removed and the samples were
washed in 1.4 ml phosphate buffered saline by centrifugation as
before, The wash was repeated twice and then the samples were
washed once in 0,85% NaCl.
Pronase (nonspecific protease) is a mixture of several proteo-
lytic enzymes, including endopeptidases and exopeptidases. The
enzyme was stored at 7.0 U/mI in phosphate buffered saline pH
7.4. One milliliter of Pronase was added per 2000 glomeruli and
incubated at 37°C with tumbling for 10 minutes unless otherwise
stated. The glomeruli were washed in phoshate buffered saline
(x3) and then in 0.85% NaCl as described above.
Trypsin digestion of glomeruli was achieved by the addition of
1.25 U of trypsin in 1.0 ml of phosphate buffered saline to —2000
glomeruli. Each sample was incubated at 37°C with tumbling for
10 minutes. The reaction was stopped by the addition of 0.1 ml of
trypsin inhibitor (2.5 mg/mI). The glomeruli were then washed as
before.
For the papain digestion, the glomeruli (—2000) were sus-
pended in 1 ml 0.85% NaC1. Samples were incubated with 0.15 ml
papain buffer (1.0 M sOdium acetate, pH 5.5 and with 0.05 M
EDTA) containing 10 mg/mI cysteine hydrochloride (added im-
mediately before use) and of papain suspension (8.2 mg/ml) at
60°C overnight.
Albumin binding assay
A total of 1.4 ml of 5% albumin perfusate solution was added
to —2,000 pelleted glomeruli. Forty microliters (—450,000 dpm)
of {3H]albumin dissolved in phosphate buffered saline was added
to each sample. The samples were resuspended and incubated for
varying times at 37°C on a Ratek tumbler (Ratek Instruments,
Mitcham, Australia) at setting 3.5. After incubation the samples
were centrifuged at 3000 rpm for 10 minutes in a KS-5200C
Kubota benchtop centrifuge at room temperature. The superna-
tant was collected for recovery analysis. The samples were resus-
pended in 1.4 ml of 0.85% NaCl and then centrifuged (3000 rpm,
10 mm). This first wash was removed and a second wash and a
third wash were performed as above. The glomeruli were then
papain digested overnight and counted on a Wallac LKB liquid
scintillation counter with a scintillant/sample ratio 3:1.
For GBM preparations the binding experiments were carried
out using the same conditions as described for isolated glomeruli
except that the incubations were performed overnight for 18 hours
at 4°C. Approximately 106 dpm of [3H}albumin was added to each
incubation mixture containing 3 to 8 mg of GBM. After incuba-
tion the samples were twice washed with 0.85% NaC1, papain
digested and counted for radioactivity as described above.
Nonspecific binding assay
Nonspecific binding of [3H]albumin to glomeruli was estimated
by using {3Hldextran T40. The incubation mixture was the same as
that described above, but in addition it contained 1 mg/mI dextran
T40 and 10 tl of [3H]dextran T40 at the same initial radioactivity
as was used for the [3H]albumin binding experiments (450,000
dpm). The quantity of radioactivity of [3H]dextran associated with
the glomeruli after two washes was assumed to be the amount of
[3H]albumin to be nonspecifically associated with the glomeruli.
This amount was subtracted from the total [3H]albumin radioac-
tivity associated with the glomeruli to calculate specific binding of
albumin.
Concentration dependence of albumin binding to glomeruli
When different concentrations of albumin were used in the
incubation media the other components in the perfusate mixture
such as the amino acids remained constant.
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Fig. 1. Binding of albumin-gold to the glomerular capillaty wall. A. A 2 mm
perfusion of a rat kidney with albumin-gold (5 nm) in phosphate buffered
saline. Magnification x41,400. The albumin-gold particles are found to be
distributed quite evenly along the lamina rara interna of the GBM. Two
particles are observed to be passing through the endothelial cell fenestrae.
The distribution of particles between endothelial cells and GBM appears
quite rapid. B. Twenty mm perfusion of albumin-gold in normal 5%
albumin perfusate. Magnification X9,700. There are essentially no albu-
min-gold particles associated with the GBM, although there is some
endothelial cell uptake as indicated by the arrows. C. A magnified section
of the arrowed area of the middle panel. Magnification X46,300.
Calculations
All quantitative data are expressed as means standard
deviation (SD) and where N represents the number of determina-
tions.
Results
Interaction of albumin-gold
For the two minute perfusion the majority of albumin-gold
particles were distributed quite regularly along the lamina rara
interna of the basement membrane (Fig. 1). There was no
significant association of albumin-gold particles with endothelial
cell surfaces. In a control experiment where albumin-gold was
perfused with normal perfusate containing 50 mg/mI albumin for
20 minutes, the labeling of the basement membrane was markedly
reduced. This demonstrates that the interactions governing albu-
min-gold-basement membrane interaction in the two minute
perfusion could be dissociated by high concentrations of unla-
beled albumin. Some internalization of albumin-gold by endothe-
hal cells was apparent, however.
Binding assay with [3H]albumin
The time dependence of 3HJalbumin binding to isolated
glomeruhi is shown in Figure 2. The rate of equilibration of
albumin interaction with the glomeruli was quite rapid where
equilibrium was obtained after 30 minutes of incubation irrespec-
tive of the number of post-binding washes. In all subsequent
binding assays with glomeruhi a 30 minute incubation has been
used as the standard binding assay condition.
When the binding assay was performed for 30 minutes a
substantial amount of albumin associated with the glomeruhi after
the first wash was essentially removed by the second wash (Fig. 2);
the third wash made no statistical difference, The marked drop in
[3H]albumin associated with glomeruli after the first post-binding
wash could simply be accounted for by free [3H]albumin that was
casually associated with glomeruli harvested by the first centrifu-
gation after the incubation. There is approximately a 1/25 dilution
of the original incubation mixture present in the harvested
glomeruli after the 0.85% NaCl wash. Any possible perturbation
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Fig. 2. The effect of incubation time and post-binding washes on the binding
of [3H]albumin to isolated glomeruli. The initial incubation mixture was
with approximately 2000 glomeruli and 50 mg/mI albumin perfusate
solution with [3H]albumin at 37°C. At the end of the incubation period the
glomeruli were separated from the incubation medium by centrifugation
and resuspended and washed in 0.85% MaCI at 4°C. The amount of
albumin bound or associated with the glomeruli after this first wash was
measured (0). The washing procedure was then repeated (second wash)
and the albumin bound to glomeruli was measured (•). Albumin bound to
glomeruli after the third wash was also measured (V). After the second
wash there appeared to be no statistically significant (P < 0.05) difference
in the amount that remained bound to the glomeruli at 30 minutes.
of the binding equilibrium during the post-binding washing pro-
cedures would appear negligible owing to the similarity of the
second and third washes. We assumed that the albumin associated
with glomeruli at the second wash reflected the equilibrium
binding interaction of the incubation mixture and used this as the
standard method to examine binding.
Nonspecific binding of [3H]albumin was estimated with the use
of [3H]dextran (average molecular weight —40,000 and hydrody-
namic radius ——40 A) that mimics the hydrodynamic radius of
albumin (radius —-36 A). In an experiment designed to test the
wash-dependence, we found that for 450,000 dpm of [3F1]dextran
initially added to 2000 glomeruli there were 882 dpm/1000
glomeruli after the first wash, 127 dpm/glomeruli after the second
wash and 53 dpm/1000 glomeruli after the third wash. The marked
drop in dpm associated with glomeruli after the second wash
confirmed the dilution effect that was seen with the wash-
dependence with [3H]albumin associated with glomeruli as de-
scribed above. It was also apparent that the amount of nonspecific
association of the dextran with glomeruli was very low, as most
incubations of glomeruli with [3H]albumin resulted in dpm/1000
glomeruli >1000.
The concentration dependence of albumin binding to isolated
glomeruli at 37° and 4°C is shown in Figure 3. Studies in Figure 3
confirm the earlier albumin-gold binding interaction with the
GCW: glomeruli bind significant quantities of albumin and that
Albumin concentration in incubation medium, mg/mi
Fig. 3. Concentration dependence of albumin binding to isolated glomeruli.
Increasing concentrations of albumin were incubated with isolated gb-
meruli (2000) at 37°C (•) and at 4°C (0) for 30 minutes. The data are
plotted in terms of bound albumin per 1000 glomeruli as a function of the
albumin concentration in the incubation media. The values of bound
albumin represent means (N = 4) so. Non-specific binding was
determined by incubating a similar quantity of radioactive [3H}dextran
T40 with isolated glomeruli under identical conditions to those used in the
albumin binding assay.
the binding increases with increasing concentration of albumin in
the incubation mixture. The binding is temperature dependent
with more bound at 37°C. In the range of 30 to 50 mg/mI there was
a 200% increase in glomerular albumin binding. The temperature
dependence of albumin binding at 50 mg/mI was statistically
significant (P < 0.05, Student's t-test).
Scatchard analysis of the data in Figure 3 is shown in Figure 4.
This analysis demonstrated that there was a binding site at 37°C
with a moderate affinity constant of 3.6 X i0 M1 (7 X i0'
molecules/glomerulus) and at 4°C the association constant was
lower at 1.1 X i0 M1 (7 X i0 molecules/glomerulus). For
studies at 37°C alone, there was anomalous behavior in the
binding of albumin at higher albumin concentrations. The reasons
for this specific temperature-dependent effect could be, in part,
due to cellular uptake of albumin which was also evident in the
albumin-gold perfusion studies, and also to the temperature
dependent generation of multiple binding sites. We demonstrate
below that, indeed, additional binding sites may he generated
through proteolytic and glycosidase treatment.
Schnitzer, Carley and Palade [14] have previously demonstrated
that albumin binding sites of confluent layers of microvascular
endothelial cells were Pronase-sensitive but trypsin resistant. The
effect of digesting glomeruli with these proteolytic enzymes on the
binding of albumin is shown in Figure 5. The most striking aspect
of these results is that Pronase digestion results in a substantial
increase in the amount of albumin bound to glomeruli; the
amount of binding was directly proportional to the time of enzyme
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digestion over a total period of 30 minutes. The Pronase enhanced
albumin binding could be inhibited by the presence of a Pronase
inhibitor EDTA in the digestion incubation mixture. Trypsin
digestion had no effect on albumin binding. Other studies on
glomerular binding are shown in Table 1. Albumin binding to
glomeruli was not influenced by the presence of protease inhibi-
tors which would indicate that the action of endogenous enzymes
were not responsible for the enhanced binding of albumin at 37°C
as compared to 4°C. Previous studies by Cohen and Surma [30]
had demonstrated that GBM glycosaminoglycans could be re-
leased by Pronase digestion. We then tested for the effect of
heparinase digestion on glomeruli, and like the result with Pro-
nase digestion, the binding of albumin to glomeruli was enhanced.
The binding was not affected by neuraminidase digestion.
The next series of experiments were designed to examine the
binding of albumin to purified GBM, as our earlier studies on
albumin-gold binding and the Pronase and heparinase effect
would suggest that albumin binding is mainly to the basement
membrane and not to endothelial cells. The results for the binding
of albumin to purified GBM preparations and glycosidase-di-
gested GBM preparations are shown in Table 2. These studies
demonstrate that albumin does bind to the purified GBM and this
binding is increased by two orders of magnitude or more by
heparinase digestion of the GBM. The other glycosidases, chon-
droitinase ABC and hyaluronidase, had no effect on GBM
albumin binding as compared to the control.
Discussion
Endogenous albumin is increasingly being recognized as a
plasma component that interacts with the vascular wall and alters
Table 1. Albumin binding to isolated glomeruli
Treatment
% Bound albumin
compared to control N
Control 100 11 10
Heparinase 212 18 14
Neuraminidase 81.4 8.0 3
Inhibitor cocktail A 89.8 48 3
Table 2. Albumin binding to glycosidase-treated glomerular basement
membrane
Treatment
% Bound albumin
compared to controla N
Control 100 27.1 13
Heparinase 8265.3 4876.9 9
Chondroitinase ABC 73.0 15.0 6
Hyaluronidase 74.0 10.4 6
° Absolute value of control 39.4 10.7 ng albumin/jtg GBM protein
its permeability. In single frog mesenteric arteries [7—9] and in
microvessel endothelial cell cultures [11, 18] it is well established
that lowering the albumin concentration alters the hydraulic flow
characteristics of the capillaiy wall. It has been proposed that
albumin can bind to endothelial cells or the glycocalyx via
albumin's arginine residues and thereby reduce permeability [8,
11, 31]. This protein effect, however, is yet to be well established
in mammalian vessels [32]. Studies in glomerular systems using
immunocytochemical techniques have demonstrated the accumu-
lation of endogenous albumin [33—351 and exogenous albumin
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Fig. 4. Scatchard plot of the binding of [3H]albumin to isolated glomeruli.
The data from Fig. 3 have been used in this Scatchard analysis. Increasing
Concentrations of unlabeled albumin were used in the incubation medium
with constant amounts of [3Hlalbumin. Concentrations of albumin ranging
from 0.25 mg/mI to 50 mg/mI were incubated with isolated glomeruli at
37°C (•) and at 4°C (0) for 30 minutes and two post-binding washes.
Values represent means (N = 4) so. The lines represent linear
regression analysis used to examine the binding data and to determine the
association constant and number of binding sites with the assumption of
one binding site at both temperatures. The binding behavior of albumin at
higher concentrations at 37°C displays anomalous characteristics.
0 5 10 15 20 25 30 35
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Fig. 5. Albumin binding to proteolytic enzyme digested glomeruli. Glomeruli
were digested with either trypsin (V) or Pronase (•) for varying times
prior to incubation with in the standard incubation mixture containing 50
mg/mI albumin. A control digestion with Pronase in the presence of the
enzyme inhibitor 2 mrvi EDTA was performed (7) as well as a no enzyme
control (LI). Values of bound albumin represent means (N = 3) SD.
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[361 in the glomerular basement membrane of functioning kid-
neys. Fujigaki et a! [35] claimed that endogenous albumin was not
bound to the GCW as a perfusion-fixed glomerulus showed no
albumin antigenic sites. It is likely, however, that the techniques
used in that study had low sensitivity, as indicated by the number
of antigenic sites that were observed in the capillary lumen of the
in situ drop-fixed glomeruli. The binding of albumin to the
glomerular capillary wall and GBM as established in this study
using high specific activity [3H]albumin and albumin-gold is
entirely consistent with the notion that albumin binding interac-
tion with glomerular capillaries may affect capillary permeability.
It was of interest to study albumin interaction with isolated
glomeruli because the glomeruli are simple to prepare and
represent the critical unit in macromolecular filtration occurring
in the kidney. However, their structures are complex and this
could possibly make the quantitative aspects of binding difficult to
interpret. Isolated glomeruli expose their epithelial cell surfaces
to binding which would not occur to any significant extent in
whole kidneys. A further aspect is that isolated glomeruli have
finite quantities of endogenous albumin that can be measured by
sonicating the isolated glomeruli and collecting the supernatant
[61. Incubation with exogenous [3Hjalbumin may result in an
initially lower specific activity of albumin in the neighborhood of
the glomerular binding sites, although the kinetics of equilibration
of [3H]albumin (Fig. 2) indicated that the exchange process of free
to bound albumin was quite rapid. We cannot eliminate, however,
sites where the exchange of endogenous albumin with [3Hlalbu-
mm was slow (>2 hr). This also raises the possibility that Pronase
digestion of glomeruli is, in part, effectively digesting endogenous
albumin off slow exchange sites, thereby making more sites
available for [3H]albumin binding. If this were the case, we would
have expected tiypsin to have a similar effect, yet it had no effect
at all; 14% of the 582 amino acid residues in bovine albumin are
lysine or arginine residues [37] that are potentially trypsin sensi-
tive, and as a result, the trypsin digestion of endogenous albumin
would be extensive. We would also expect that trypsin, with a
molecular weight of only 23,000, would have good access to
potential substrates as compared to Pronase which is a mixture of
a number of proteascs of varying size. Another potential action of
both Pronase and heparinase is that these enzymes release cells
from glomeruli thereby exposing underlying binding sites. In this
context it is intriguing that albumin appears to associate with the
GBM quite evenly along the structure, particularly to what
appears to he under endothelial cells (Fig. 1) [351 as if removal of
cells would not make much difference.
Perhaps the most compelling evidence that the albumin binding
sites arc, in part, derived from the glomerular basement mem-
brane is that the enhanced number of sites generated in isolated
glomeruli that have been digested with heparinase is also mir-
rored in heparinase digested GBM where much of the cellular
material has been removed. At a quantitative level the yield of
GBM from glomeruli is approximately 0.2mg wet weight per 1000
glomeruli [28]. Since the albumin binding to GBM was —3 j.tg/mg
GBM this would translate to albumin binding of —0.6 gI1000
glomeruli or in the case of heparan sulphate depleted GBM a
value of 120 j.rgIlOO() glomeruli. This range of values compares
favourably with glomerular levels of albumin obtained in isolated
perfused kidneys which ranged from 0 to 60 j.rgIl000 glomeruli [6].
The values obtained for albumin binding to isolated glomeruli
were in the range of 10 to 60 gIi000 glomeruli or up to 250
/.Lg/1000 for Pronase digested glomeruli which would indicate that
other elements of the glomeruli, such as epithelial cells, may bind
albumin in this case.
The mechanism of albumin binding to GCW components is
probably ionic. The albumin molecule is highly polar with 182
charged residues, of which 100 are negative and 82 positive [371.
Previous studies have implicated the cationic group of the argi-
nine residue as being involved in the electrostatic interaction with
negatively charged groups of components of the GCW [8, 11, 31].
It is to be noted that all our incubation mixtures contained free
amino acids, including 0.5 mivi arginine, which would effectively
compete with albumin even at 50 mglml (or 0.75 mM). The binding
of albumin to heparan sulfate-depleted glomeruli and GBM must
then be either to type IV collagen or other GBM components
such as laminin. In normal states heparan sulphate may mask
these binding sites through excluded volume interactions with
endogenous albumin or charge-charge interactions, although the
latter is less likely [2].
The results in this study confirm a suggestion made previously
that GBM heparan sulfate acts an anticlogging factor [4]. In that
study when the ionic strength of the perfusate for perfused
kidneys was increased, and when the influence of electrostatic
interactions decreased, there was considerable clogging observed
with native ferritin, a decreased permeability to '251-insulin, and a
reduced glomerular filtration rate. These events bear a marked
resemblance to our studies of the renal handling of albumin in
perfused kidneys. We have previously demonstrated that isolated
perfused kidneys are partially ischemic [38], and that this results,
through production and action of oxygen free radicals, in a loss of
glomerular heparan sulfate which can be inhibited by the presence
of a cocktail of oxygen free radical scavengers in the perfusate.
The fact that there is heparan sulfate loss would suggest, from
results in the present study, that there would be a perfusion time:
dependent accumulation of albumin in the glomerulus, which is
exactly what is observed [6]. This is accompanied by a perfusion
time-dependent proteinuria and decrease in glomerular filtration
rate [21, 38].
The significance of the anticlogging properties of heparan
sulfate and the availability of GCW albumin binding sites still has
to be substantiated by in vivo studies, it is known, for example,
that the serum factor, orosomucoid, not present in normal
perfusates, is known to affect albumin permeability [39—41] and
potentially can affect albumin interaction with capillary walls,
possibly by binding to endothelial cells [42].
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